Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × gallium maltolate × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1 Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1 Prostatic Neoplasms 1 Multiple Myeloma 1 Lymphoma 1

Interventions

resiquimod 1 poly ICLC 1 gallium maltolate 1 fludarabine 1 cc-486 1 Vorinostat 1 Thalidomide 1 Social Determinants of Health 1 Injections 1 In Situ Hybridization, Fluorescence 1 Fentanyl 1 Docetaxel 1 Cyclophosphamide 1 Azacitidine 1 Antineoplastic Protocols 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00050687 2011-01-28

Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies

Titan Pharmaceuticals

Phase 1/2 Terminated

GenitourinaryLymphoidPlasma cell

Urinary Bladder Neoplasms, Lymphoma, Multiple Myeloma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡